Literature DB >> 19960958

The mechanisms of medically refractory temporal lobe epilepsy.

Sirichai Chayasirisobhon1.   

Abstract

The mechanisms underlying the refractory temporal lobe epilepsy (TLE) are not well understood. Several explanations for refractory TLE are (1) an overexpression of P-glycoprotein (P-gp) encoded by multiple drug resistance 1 (MDR1) gene and other efflux transporters such as multidrug resistance protein (MRP) in the cerebrovascular endothelium in or around the region of the epileptic focus may lead to drug resistance in epilepsy; (2) the loss of antiepileptic drug sensitivity at certain target sites in the brain, including the sodium ion channel and the gamma aminobutyric acid (GABA)A receptor; and (3) seizures beget seizures by means of a cascade of events that include various types of neuronal damage, sprouting of neuronal axons and new synapse formations that establish aberrant glutamatergic synapses. TLE may be a progressive neurological disorder that requires early and effective treatment. Early recognition of refractory TLE and referral for epilepsy surgery may prevent years of unnecessary seizure activity and its consequences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960958

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  5 in total

1.  Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery.

Authors:  Nasir Mirza; Olga Vasieva; Anthony Guy Marson; Munir Pirmohamed
Journal:  Hum Mol Genet       Date:  2011-08-18       Impact factor: 6.150

2.  Intranasal Delivery of miR-146a Mimics Delayed Seizure Onset in the Lithium-Pilocarpine Mouse Model.

Authors:  Hua Tao; Jianghao Zhao; Tingting Liu; Yujie Cai; Xu Zhou; Huaijie Xing; Yan Wang; Mingkang Yin; Wangtao Zhong; Zhou Liu; Keshen Li; Bin Zhao; Haihong Zhou; Lili Cui
Journal:  Mediators Inflamm       Date:  2017-01-24       Impact factor: 4.711

Review 3.  Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models.

Authors:  Noemi Cardenas-Rodriguez; Bernardino Huerta-Gertrudis; Liliana Rivera-Espinosa; Hortencia Montesinos-Correa; Cindy Bandala; Liliana Carmona-Aparicio; Elvia Coballase-Urrutia
Journal:  Int J Mol Sci       Date:  2013-01-14       Impact factor: 5.923

4.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

5.  Promoter Variants of the ADAM10 Gene and Their Roles in Temporal Lobe Epilepsy.

Authors:  Hua Tao; Jianghao Zhao; Xu Zhou; Zhonghua Ma; Ying Chen; Fuhai Sun; Lili Cui; Haihong Zhou; Yujie Cai; Yanyan Chen; Shu Zhao; Lifen Yao; Bin Zhao; Keshen Li
Journal:  Front Neurol       Date:  2016-06-30       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.